Repligen (RGEN)'s Hidden ValueDespite a daily loss of 3.9% and a 3-month loss of 3.4%, Repligen Corp (NASDAQ:RGEN) shows a promising Earnings Per Share (EPS) of 2.42. This raises a compelling question: Is the stock significantly undervalued?
Repligen Corp is a leading life sciences company with a global presence. It is renowned
